Could charcoal and probiotics protect kidneys in diabetes?

NCT ID NCT07333313

Recruiting now Disease control Sponsor: National Taiwan University Hospital Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether taking activated bamboo charcoal and probiotics can reduce inflammation and slow kidney disease in people with diabetes. About 300 participants with different stages of chronic kidney disease will receive one or both treatments for 6 months. Researchers will track kidney function and markers of inflammation over a year.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: activated bamboo charcoal and probiotics
What this could lead to: If successful, this could offer a simple, non-drug way to slow kidney damage in people with diabetes.
What could go wrong: This is an early-stage study with no phase designation, and the effects of charcoal and probiotics on kidney function are not yet proven. Results may not lead to a standard treatment.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DIABETIC KIDNEY DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

diabetic kidney disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ORAL UREMIC TOXIN ABSORBENT

Contacts and locations

Locations

National Taiwan University Hospital.
RECRUITING

Taipei, Taiwan, 10002, Taiwan

More trials for these conditions

Other studies related to the condition(s) this trial covers.